reported that BCL2 expression was a strong prognostic factor in the HRc(+)/HER2(−) subtype 20 , whereas BCL2 expression had only marginal significance in the HRc(+)/HER2(+) subtype, and it was not a significant prognosticator in the HRc(−)/HER2(+) and HRc(−)/HER2(−) subtypes.
← all excerpts
Prognostic influences of BCL1 and BCL2 expression on disease-free survival in breast cancer.
1
—
—